UPMC Hillman Cancer Center | Strategic Alliance Partners

Latest from UPMC Hillman Cancer Center

Toxicity Management Remains Key With Expanding Frontline Treatment Options in Lung Cancer

October 25, 2021

Antoinette Wozniak, MD, FACP, FASCO, highlights the importance of monitoring patients with lung cancer for toxicities and significant advances on the horizon that are expected to further expand the lung cancer armamentarium.

Hematology: Chaired by Mounzer E. Agha, MD

November 10, 2020

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of hematologic oncology.